Valsartan: now it's Austria's turn

From Dr Ernst Tremmel (Partner, Wiltschek Rechtsanwälte, Vienna) comes new that, in the recent past, an Austrian first instance court has delivered its judgment in the main proceedings, holding that a Valsartan/HCTZ product infringes the mono SPC for Valsartan. He tells us that, though the judgment is not yet final, he thought it might be of interest both for us at The SPC Blog and for our readers, so he has kindly furnished us with (i) a short English-language summary of the decision and (ii) the anonymised German-language version of the judgment. It is is hope that, within the next few days, he will be able to send us also an unofficial English translation.

Thanks, so much Ernst, both for this information and for your offer to deal with any questions arising out of these attachments.